Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review.

This study aims to review the pharmacological and safety profile of LF with a focus on the LF-induced hepatic injury from the perspective of pathophysiology and possible protective agents.
PMID: 33571819 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - February 8, 2021 Category: Allergy & Immunology Authors: Alamri RD, Elmeligy MA, Albalawi GA, Alquayr SM, Alsubhi SS, El-Ghaiesh SH Tags: Int Immunopharmacol Source Type: research